Freeze-drying, or lyophilisation, is a well-known technique for preserving solids by extracting water. This technique is often used within the medical industry to develop new pharmaceuticals and biomaterials as well as processing a range of soft and hard tissue. As a comparatively mild preservation technique, freeze-drying enables you to retain the original structure of a biomaterial or tissue which improves graft-adherence in the clinical setting.
Freeze-dried products generally have a longer shelf life and can be stored at room temperature. It also has the added benefit of not requiring the use of (chemical) preservatives and it can help you reduce costs and lower your environmental footprint by virtue of the fact that it does not require the use of a cold storage facility.
EMCM, a Leader Biomedical Group company, offers a range of freeze-drying services for a wide variety of applications at various production scales. Our state-of-the-art Zirbus freeze-dryer has been fully qualified for GMP use as of 1 January 2013. It has a 40 kg/hour condenser capacity and volume size of 0.8 by 1 meter. In addition to the Zirbus, we also have a more compact freeze-dryer that is ideal for smaller batches to improve the flexibility of our customer offering.
We have several years experience in medical contract manufacturing and have worked with a large variety of biomedical products. Over the years, our staff have honed their ability to adapt our freeze-drying technology to meet the stringent requirements of our diverse customer cases. We are able to freeze-dry tissue to improve storage, process a variety of pharmaceutical products, manufacture complex powders, and coat pharmaceutical products such as antibiotics.